1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) follow-up of CheckMate 649
    Meeting Abstract

    Shitara, K.; Moehler, M. H.; Ajani, J. A.; Shen, L.; Garrido, M.; Gallardo, C.; Wyrwicz, L. S.; Yamaguchi, K.; Cleary, J. M.; Elimova, E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007
    Meeting Abstract

    Ku, G. Y.; Moughan, J.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Mehta, R.; Klempner, S. J.; Miller, E. D.; Hong, T. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Trivedi, N.; Maron, S. B.; Joshi, S. S.; Ilson, D. H.; Janjigian, Y. Y.; Shcherba, M.; Li, J.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results
    Meeting Abstract

    Janjigian, Y. Y.; Kawazoe, A.; Xu, J.; Lonardi, S.; Metges, J. P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; Bilici, M.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Identification of somatic alterations associated with brain metastases from a colorectal origin
    Meeting Abstract

    Strong, J. S.; Drebin, H. M.; Walch, H. S.; Gui, C.; Pike, L. R. G.; Moss, N. S.; Sanchez-Vega, F.; Smith, J. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
    Meeting Abstract

    Janjigian, Y. Y.; Al-Batran, S. E.; Wainberg, Z. A.; Van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L. S.; Oh, D. Y.; Omori, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quality of life (QOL) for patients with esophageal cancer receiving trimodality therapy with induction chemotherapy, chemoradiation, and surgery: Results from CALGB 80803 (alliance)
    Meeting Abstract

    Goodman, K. A.; Dueck, A. C.; Fruth, B.; Noonan, A. M.; Shergill, A.; Bekaii-Saab, T. S.; O'Reilly, E. M.; Meyerhardt, J. A.; Ilson, D. H.; Deshields, T. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • BRAF variants and oncogenic fusions to define sporadic MMR-deficient colorectal cancer subtypes
    Meeting Abstract

    Abdelfattah, S.; Harada, G.; Patel, S.; Artz, O.; Yaeger, R.; Johannet, P.; Harrold, E.; Walch, H. S.; Argiles, G.; Rousseau, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Early identification and treatment of occult metastatic disease in stage III colon cancer (SU2C ACT3 clinical trial)
    Meeting Abstract

    Pappas, L.; Yaeger, R.; Kasi, P. M.; Shah, M. A.; Azad, N. S.; Horick, N. K.; Corcoran, R. B.; Diaz, L. A.; Parikh, A. R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C-mutated colorectal cancer
    Meeting Abstract

    Yaeger, R.; Langer, C. J.; Ruffinelli, J. C.; Fakih, M.; Furqan, M.; Machiels, J. P. H.; Saportas, Y.; Nolte-Hippenmeyer, J.; Chan, E.; Xia, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save